Drug Type Bispecific antibody |
Synonyms- |
Target |
Mechanism KMA inhibitors(KMA inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization HaemaLogiX Pty Ltd.Startup |
Active Organization- |
Inactive Organization HaemaLogiX Pty Ltd.Startup |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Myeloma | Discovery | US | HaemaLogiX Pty Ltd.Startup | 20 Jul 2020 |